4-PHENYL-5-M-TOLYLOXYMETHYL-4H-[1,2,4]TRIAZOLE-3-THIOL
- $378 - $874
- Product name: 4-PHENYL-5-M-TOLYLOXYMETHYL-4H-[1,2,4]TRIAZOLE-3-THIOL
- CAS: 76659-61-5
- MF: C16H15N3OS
- MW: 297.37
- EINECS:
- MDL Number:MFCD00618582
- Synonyms:4-PHENYL-5-M-TOLYLOXYMETHYL-4H-[1,2,4]TRIAZOLE-3-THIOL;3-[(3-methylphenoxy)methyl]-4-phenyl-1H-1,2,4-triazole-5-thione;3H-1,2,4-Triazole-3-thione, 2,4-dihydro-5-[(3-methylphenoxy)methyl]-4-phenyl-;4-Phenyl-5-((m-tolyloxy)methyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione
3 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Crysdot
- Matrix Scientific
Package
- 500MG
- 1g
- 5g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0086806
- Product description4-PHENYL-5-M-TOLYLOXYMETHYL-4H-[1,2,4]TRIAZOLE-3-THIOL 95.00%
- Packaging500MG
- Price$777.32
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11060181
- Product description4-Phenyl-5-((m-tolyloxy)methyl)-4H-1,2,4-triazole-3-thiol 97%
- Packaging5g
- Price$874
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number018394
- Product description4-Phenyl-5-m-tolyloxymethyl-4H-[1,2,4]triazole-3-thiol
- Packaging1g
- Price$378
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | CHM0086806 | 4-PHENYL-5-M-TOLYLOXYMETHYL-4H-[1,2,4]TRIAZOLE-3-THIOL 95.00% | 500MG | $777.32 | 2021-12-16 | Buy |
Crysdot | CD11060181 | 4-Phenyl-5-((m-tolyloxy)methyl)-4H-1,2,4-triazole-3-thiol 97% | 5g | $874 | 2021-12-16 | Buy |
Matrix Scientific | 018394 | 4-Phenyl-5-m-tolyloxymethyl-4H-[1,2,4]triazole-3-thiol | 1g | $378 | 2021-12-16 | Buy |
Properties
Boiling point :431.9±47.0 °C(Predicted)
Density :1.24±0.1 g/cm3(Predicted)
pka :4.90±0.20(Predicted)
Density :1.24±0.1 g/cm3(Predicted)
pka :4.90±0.20(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|